Vitamin D Deficiency and Outcome of COVID-19 Patients

Radujkovic et al., Nutrients 2020, 12:9, 2757, doi:10.3390/nu12092757, Sep 2020

Source

PDF

All
Studies

Meta
Analysis

https://c19early.org/radujkovic.html

Vitamin D for COVID-19

8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 125 studies, recognized in 18 countries.

Lower risk for mortality, ICU, hospitalization, progression, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,700+ studies for 151 treatments. c19early.org

Observational study 185 patients in Germany shows an association between vitamin D status and severity and mortality. Adjusted hazard ratio of vitamin D sufficiency for combined mechanical ventilation and death was HR 0.16, p < 0.001, and for death HR 0.068, p < 0.001.

This is the 14th of 218 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 25,894,433,917 vigintillion).

Important missing comments or errors? Let us know.

risk of death, 93.2% lower, HR 0.07, p = 0.001, high D levels 144, low D levels 12, >30nmol/L.

risk of death/intubation, 84.0% lower, HR 0.16, p < 0.001, high D levels 144, low D levels 12, >30nmol/L.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Radujkovic et al., 10 Sep 2020, prospective, Germany, peer-reviewed, 6 authors.

This Paper Vitamin D All

Vitamin D Deficiency and Outcome of COVID-19 Patients

Aleksandar Radujkovic, Theresa Hippchen, Shilpa Tiwari-Heckler, Saida Dreher, Monica Boxberger, Uta Merle

Nutrients, doi:10.3390/nu12092757

Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses an enormous challenge to health care systems throughout the world. Without causal treatment, identification of modifiable prognostic factors may help to improve outcomes. To explore possible associations of vitamin D (VitD) status with disease severity and survival, we studied 185 patients diagnosed with coronavirus disease 2019 (COVID-19) and treated at our center. VitD status at first presentation was assessed retrospectively using accredited laboratory methods. VitD deficiency was defined as serum total 25-hydroxyvitamin D level < 12 ng/mL (<30 nM). Primary endpoint was severe course of disease (i.e., need for invasive mechanical ventilation and/or death, IMV/D). Within a median observation period of 66 days (range 2-92), 23 patients required IMV. A total of 28 patients had IMV/D, including 16 deaths. Ninety-three (50%) patients required hospitalization (inpatient subgroup). A total of 41 (22%) patients were VitD deficient. When adjusted for age, gender, and comorbidities, VitD deficiency was associated with higher risk of IMV/D and death (HR 6.12, 95% CI 2.79-13.42, p < 0.001 and HR 14.73, 95% CI 4.16-52.19, p < 0.001, respectively). Similar correlations were observed in the inpatient subgroup. Our study demonstrates an association between VitD deficiency and severity/mortality of COVID-19, highlighting the need for interventional studies on VitD supplementation in SARS-CoV-2 infected individuals.

Conflicts of Interest: The authors declare no competing financial interest. Appendix A

References

Arboleda, Urcuqui-Inchima, Vitamin, Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? Front, Immunol, doi:10.3389/fimmu.2020.01523

Charoenngam, Holick, Immunologic Effects of Vitamin D on Human Health and Disease, Nutrients, doi:10.3390/nu12072097

Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet, doi:10.1016/S0140-6736(20)30211-7

D'avolio, Avataneo, Manca, Cusato, De Nicolò et al., 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359

Dong, Du, Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect. Dis, doi:10.1016/S1473-3099(20)30120-1

Faul, Kerley, Love, O'neill, Cody et al., Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection, Ir. Med. J

Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, doi:10.3390/nu12040988

Hippchen, Kräusslich, Merle, Coronataxi brings outpatient care to covid-19 patients, Ann. Emerg. Med, doi:10.1016/j.annemergmed.2020.06.001

Holick, Vitamin, Deficiency, None, N. Engl. J. Med, doi:10.1056/NEJMra070553

Isaia, Medico, Associations between hypovitaminosis D and COVID-19: A narrative review, Aging Clin. Exp. Res, doi:10.1007/s40520-020-01650-9

Jakovac, COVID-19 and vitamin D-Is there a link and an opportunity for intervention?, Am. J. Physiol. Metab, doi:10.1152/ajpendo.00138.2020

Marik, Kory, Varon, Does vitamin D status impact mortality from SARS-CoV-2 infection?, Med. Drug Discov, doi:10.1016/j.medidd.2020.100041

Martineau, Forouhi, Vitamin D for COVID-19: A case to answer?, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(20)30268-0

Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583

Mitchell, Vitamin-D and COVID-19: Do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(20)30183-2

Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J. Med. Virol, doi:10.1002/jmv.26360

Rabenberg, Scheidt-Nave, Busch, Rieckmann, Hintzpeter et al., Vitamin D status among adults in Germany-results from the German Health Interview and Examination Survey for Adults (DEGS1), BMC Public Health, doi:10.1186/s12889-015-2016-7

Rhodes, Subramanian, Laird, Kenny, Editorial: Low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity, Aliment. Pharmacol. Ther, doi:10.1111/apt.15777

Schemper, Smith, A note on quantifying follow-up in studies of failure time, Control. Clin. Trials, doi:10.1016/0197-2456(96)00075-X

Shi, Yu, Zhao, Wang, Zhao et al., Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan, Crit. Care, doi:10.1186/s13054-020-2833-7

Verity, Okell, Dorigatti, Winskill, Whittaker et al., Estimates of the severity of coronavirus disease 2019: A model-based analysis, Lancet Infect. Dis, doi:10.1016/S1473-3099(20)30243-7

Yang, Zheng, Gou, Pu, Chen et al., Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis, Int. J. Infect. Dis, doi:10.1016/j.ijid.2020.03.017

DOI record: { "DOI": "10.3390/nu12092757", "ISSN": [ "2072-6643" ], "URL": "http://dx.doi.org/10.3390/nu12092757", "abstract": "Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses an enormous challenge to health care systems throughout the world. Without causal treatment, identification of modifiable prognostic factors may help to improve outcomes. To explore possible associations of vitamin D (VitD) status with disease severity and survival, we studied 185 patients diagnosed with coronavirus disease 2019 (COVID-19) and treated at our center. VitD status at first presentation was assessed retrospectively using accredited laboratory methods. VitD deficiency was defined as serum total 25-hydroxyvitamin D level < 12 ng/mL (<30 nM). Primary endpoint was severe course of disease (i.e., need for invasive mechanical ventilation and/or death, IMV/D). Within a median observation period of 66 days (range 2–92), 23 patients required IMV. A total of 28 patients had IMV/D, including 16 deaths. Ninety-three (50%) patients required hospitalization (inpatient subgroup). A total of 41 (22%) patients were VitD deficient. When adjusted for age, gender, and comorbidities, VitD deficiency was associated with higher risk of IMV/D and death (HR 6.12, 95% CI 2.79–13.42, p < 0.001 and HR 14.73, 95% CI 4.16–52.19, p < 0.001, respectively). Similar correlations were observed in the inpatient subgroup. Our study demonstrates an association between VitD deficiency and severity/mortality of COVID-19, highlighting the need for interventional studies on VitD supplementation in SARS-CoV-2 infected individuals.", "alternative-id": [ "nu12092757" ], "author": [ { "affiliation": [], "family": "Radujkovic", "given": "Aleksandar", "sequence": "first" }, { "affiliation": [], "family": "Hippchen", "given": "Theresa", "sequence": "additional" }, { "affiliation": [], "family": "Tiwari-Heckler", "given": "Shilpa", "sequence": "additional" }, { "affiliation": [], "family": "Dreher", "given": "Saida", "sequence": "additional" }, { "affiliation": [], "family": "Boxberger", "given": "Monica", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1386-3350", "affiliation": [], "authenticated-orcid": false, "family": "Merle", "given": "Uta", "sequence": "additional" } ], "container-title": "Nutrients", "container-title-short": "Nutrients", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2020, 9, 10 ] ], "date-time": "2020-09-10T13:10:09Z", "timestamp": 1599743409000 }, "deposited": { "date-parts": [ [ 2020, 9, 10 ] ], "date-time": "2020-09-10T13:30:33Z", "timestamp": 1599744633000 }, "indexed": { "date-parts": [ [ 2024, 4, 8 ] ], "date-time": "2024-04-08T18:36:22Z", "timestamp": 1712601382441 }, "is-referenced-by-count": 297, "issue": "9", "issued": { "date-parts": [ [ 2020, 9, 10 ] ] }, "journal-issue": { "issue": "9", "published-online": { "date-parts": [ [ 2020, 9 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 9, 10 ] ], "date-time": "2020-09-10T00:00:00Z", "timestamp": 1599696000000 } } ], "link": [ { "URL": "https://www.mdpi.com/2072-6643/12/9/2757/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1968", "original-title": [], "page": "2757", "prefix": "10.3390", "published": { "date-parts": [ [ 2020, 9, 10 ] ] }, "published-online": { "date-parts": [ [ 2020, 9, 10 ] ] }, "publisher": "MDPI AG", "reference": [ { "DOI": "10.1016/S1473-3099(20)30120-1", "doi-asserted-by": "publisher", "key": "ref1" }, { "DOI": "10.1016/S0140-6736(20)30211-7", "doi-asserted-by": "publisher", "key": "ref2" }, { "DOI": "10.1016/j.ijid.2020.03.017", "doi-asserted-by": "publisher", "key": "ref3" }, { "DOI": "10.1186/s13054-020-2833-7", "doi-asserted-by": "publisher", "key": "ref4" }, { "DOI": "10.3390/nu12072097", "doi-asserted-by": "publisher", "key": "ref5" }, { "DOI": "10.1056/NEJMra070553", "doi-asserted-by": "publisher", "key": "ref6" }, { "DOI": "10.1136/bmj.i6583", "doi-asserted-by": "publisher", "key": "ref7" }, { "DOI": "10.1016/j.medidd.2020.100041", "doi-asserted-by": "publisher", "key": "ref8" }, { "DOI": "10.1016/S2213-8587(20)30183-2", "doi-asserted-by": "publisher", "key": "ref9" }, { "DOI": "10.1111/apt.15777", "doi-asserted-by": "publisher", "key": "ref10" }, { "DOI": "10.3390/nu12040988", "doi-asserted-by": "publisher", "key": "ref11" }, { "DOI": "10.1007/s40520-020-01650-9", "doi-asserted-by": "publisher", "key": "ref12" }, { "DOI": "10.1152/ajpendo.00138.2020", "doi-asserted-by": "publisher", "key": "ref13" }, { "DOI": "10.3389/fimmu.2020.01523", "doi-asserted-by": "publisher", "key": "ref14" }, { "key": "ref15", "unstructured": "Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19https://www.rki.de/DE/Content/Kommissionen/Stakob/Stellungnahmen/Stellungnahme-Covid-19_Therapie_Diagnose.html" }, { "DOI": "10.1016/S1473-3099(20)30243-7", "doi-asserted-by": "publisher", "key": "ref16" }, { "DOI": "10.1016/j.annemergmed.2020.06.001", "doi-asserted-by": "publisher", "key": "ref17" }, { "DOI": "10.1016/0197-2456(96)00075-X", "doi-asserted-by": "publisher", "key": "ref18" }, { "article-title": "Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium", "key": "ref19", "series-title": "Dietary Reference Intakes for Calcium and Vitamin D", "year": "2011" }, { "DOI": "10.1016/S2213-8587(20)30268-0", "doi-asserted-by": "publisher", "key": "ref20" }, { "DOI": "10.3390/nu12051359", "doi-asserted-by": "publisher", "key": "ref21" }, { "DOI": "10.1002/jmv.26360", "doi-asserted-by": "publisher", "key": "ref22" }, { "article-title": "Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection", "author": "Faul", "first-page": "84", "journal-title": "Ir. Med. J.", "key": "ref23", "volume": "113", "year": "2020" }, { "DOI": "10.1186/s12889-015-2016-7", "doi-asserted-by": "publisher", "key": "ref24" } ], "reference-count": 24, "references-count": 24, "relation": {}, "resource": { "primary": { "URL": "https://www.mdpi.com/2072-6643/12/9/2757" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Food Science", "Nutrition and Dietetics" ], "subtitle": [], "title": "Vitamin D Deficiency and Outcome of COVID-19 Patients", "type": "journal-article", "volume": "12" }

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0